We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Vanguard Health Care ETF
VHT
$18.7B
| $28.2K | ﹤0.01% |
115
-81
| -41% | -$19.7K |
|
927
Chord Energy
CHRD
$7.39B
| $28K | ﹤0.01% |
182
+37
| +26% | +$5.37K |
|
928
PLDT
PHI
$4.33B
| $27.9K | ﹤0.01% |
1,193
+45
| +4% | +$1.01K |
|
929
JB Hunt Transport Services
JBHT
$25.2B
| $27.9K | ﹤0.01% |
154
+4
| +3% | +$696 |
|
930
Transmedics
TMDX
$2.91B
| $27.8K | ﹤0.01% |
331
-8
| -2% | -$612 |
|
931
Charles River Laboratories
CRL
$12.8B
| $27.8K | ﹤0.01% |
132
+65
| +97% | +$12.9K |
|
932
Howmet Aerospace
HWM
$112B
| $27.7K | ﹤0.01% |
559
+27
| +5% | +$1.2K |
|
933
Fresenius Medical Care
FMS
$12.9B
| $27.6K | ﹤0.01% |
1,154
+12
| +1% | +$275 |
|
934
United Parks & Resorts
PRKS
$2.12B
| $27.4K | ﹤0.01% |
490
+56
| +13% | +$3.16K |
|
|
JNPR
935
DELISTED
Juniper Networks
JNPR
| $27.4K | ﹤0.01% |
875
+40
| +5% | +$1.23K |
|
936
Rapid7
RPD
$773M
| $27.3K | ﹤0.01% |
604
| – | – |
|
937
BILL Holdings
BILL
$4.78B
| $27.3K | ﹤0.01% |
234
+92
| +65% | +$8.74K |
|
938
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $27.3K | ﹤0.01% |
580
| – | – |
|
939
Freshpet
FRPT
$3.22B
| $27.3K | ﹤0.01% |
415
-4
| -1% | -$262 |
|
940
Restaurant Brands International
QSR
$25.8B
| $27.2K | ﹤0.01% |
351
+26
| +8% | +$1.88K |
|
941
New Oriental
EDU
$8.98B
| $27K | ﹤0.01% |
683
-23
| -3% | -$920 |
|
942
Boot Barn
BOOT
$4.95B
| $26.9K | ﹤0.01% |
318
-8
| -2% | -$587 |
|
943
Agnico Eagle Mines
AEM
$90.5B
| $26.9K | ﹤0.01% |
538
+27
| +5% | +$1.46K |
|
|
PPL
944
PPL Corp
PPL
$26.7B
| $26.9K | ﹤0.01% |
1,016
-191
| -16% | -$5.27K |
|
945
Donnelley Financial Solutions
DFIN
$1.16B
| $26.8K | ﹤0.01% |
589
| – | – |
|
946
Alliant Energy
LNT
$18B
| $26.8K | ﹤0.01% |
511
+10
| +2% | +$536 |
|
947
WesBanco
WSBC
$4B
| $26.8K | ﹤0.01% |
1,046
+830
| +384% | +$21.6K |
|
948
CF Industries
CF
$17.3B
| $26.7K | ﹤0.01% |
385
-35
| -8% | -$2.44K |
|
949
Future FinTech Group
FTFT
$1.47M
| $26.7K | ﹤0.01% |
128
| – | – |
|
950
Coca-Cola Femsa
KOF
$23.2B
| $26.7K | ﹤0.01% |
320
| – | – |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.